RAYMOND JAMES FINANCIAL INC

Rule 144 filings by Raymond James insider Steven M. Raney show routine, compliant sales that barely move the stock, but signal strong governance and liquidity for investors.

Raymond James boosts its stake in JinkoSolar, citing strong earnings, supply‑chain control and EU green‑deal incentives—insight into why the solar‑module leader stands out.

Raymond James Financial’s analyst outlook: a moderate‑buy consensus with target $42‑44 amid fee pressure, regulatory shifts, and growing ESG/tech initiatives.

Raymond James Financial faces analyst upgrades, but a deeper look shows hidden conflicts, volatile trading gains, and rising compliance costs that challenge its growth narrative.

Raymond James downgrades Phillips 66 to Hold, raising the target price amid earnings beats and insider moves—unpacking the shift’s impact on investors, employees, and communities.

Raymond James keeps its Q2 2026 portfolio balanced, boosting positions in Ginkgo Bioworks, Upwork, and Fidelity’s consumer‑discretionary ETF for steady, diversified growth.

Raymond James backs growth‑led stocks: strong‑buy on Alphabet for AI & cloud, U.S. Bancorp’s earnings boost, and Prologis’ logistics boom. Discover the brokerage’s insights on high‑potential sectors.

Raymond James expands coverage of Red River Bancshares & First Bancorp, noting earnings beats, ROE strengths, revenue gaps and valuation cautions.

Raymond James lifts CCL Industries target price, but analysts should scrutinize earnings assumptions, conflict of interest, and the company’s real‑world impact on workers and suppliers.

Raymond James reports steady Q1 2026 asset growth driven by private‑client gains and rising fee‑based accounts, highlighting its resilient fee‑based model and strategic diversification.